These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 23049732

  • 1. Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage.
    Hänggi D, Perrin J, Eicker S, Beseoglu K, Etminan N, Kamp MA, Heiroth HJ, Bege N, Macht S, Frauenknecht K, Sommer C, Kissel T, Steiger HJ.
    PLoS One; 2012; 7(9):e42597. PubMed ID: 23049732
    [Abstract] [Full Text] [Related]

  • 2. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model.
    Hänggi D, Eicker S, Beseoglu K, Rapp M, Perrin J, Nawatny J, Turowski B, Sommer C, Steiger HJ.
    Neurosurgery; 2009 Jun; 64(6):1155-9; discussion 1159-61. PubMed ID: 19487896
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cisternal sustained release dihydropyridines for subarachnoid hemorrhage.
    Cook DJ, Kan S, Ai J, Kasuya H, Macdonald RL.
    Curr Neurovasc Res; 2012 May; 9(2):139-48. PubMed ID: 22475399
    [Abstract] [Full Text] [Related]

  • 7. Immediate angiographic control after intra-arterial nimodipine administration underestimates the vasodilatory effect.
    Zaeske C, Zopfs D, Laukamp K, Lennartz S, Kottlors J, Goertz L, Stetefeld H, Hof M, Abdullayev N, Kabbasch C, Schlamann M, Schönfeld M.
    Sci Rep; 2024 Mar 14; 14(1):6154. PubMed ID: 38486099
    [Abstract] [Full Text] [Related]

  • 8. Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats.
    Zhao WJ, Wu C.
    Int J Neurosci; 2012 Oct 14; 122(10):611-7. PubMed ID: 22694164
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intrathecal dotarizine and nimodipine treatments in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.
    Onal MB, Solmaz I, Civelek E, Kircelli A, Tehli O, Izci Y, Erdogan E, Gonul E.
    Acta Neurochir Suppl; 2011 Oct 14; 110(Pt 2):55-60. PubMed ID: 21125446
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
    Mijailovic M, Lukic S, Laudanovic D, Folic M, Folic N, Jankovic S.
    Adv Clin Exp Med; 2013 Oct 14; 22(1):101-9. PubMed ID: 23468268
    [Abstract] [Full Text] [Related]

  • 12. Comparison of intrathecal flunarizine and nimodipine treatments in cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.
    Civelek E, Solmaz I, Onal MB, Kircelli A, Temiz C, Secer HI, Izci Y, Gonul E.
    Acta Neurochir Suppl; 2011 Oct 14; 110(Pt 2):69-73. PubMed ID: 21125448
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage.
    Hui C, Lau KP.
    Clin Radiol; 2005 Sep 14; 60(9):1030-6. PubMed ID: 16124986
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.
    Onal MB, Civelek E, Kircelli A, Solmaz I, Ugurel S, Narin F, Isikay I, Bilginer B, Yakupoglu H.
    Acta Neurochir Suppl; 2011 Sep 14; 110(Pt 2):23-8. PubMed ID: 21125440
    [Abstract] [Full Text] [Related]

  • 17. Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats.
    Gul S, Bahadir B, Hanci V, Acikgoz S, Bektas S, Ugurbas E, Ankarali H, Kalayci M, Acikgoz B.
    J Clin Neurosci; 2010 May 14; 17(5):608-11. PubMed ID: 20188570
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage.
    Washington CW, Derdeyn CP, Dhar R, Arias EJ, Chicoine MR, Cross DT, Dacey RG, Han BH, Moran CJ, Rich KM, Vellimana AK, Zipfel GJ.
    J Neurosurg; 2016 Feb 14; 124(2):318-27. PubMed ID: 26314998
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.